Turnstone Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	55	59	-	-
Enterprise Value	-20	-33	-77	-159
PE Ratio	-	-1.06	-	-
PS Ratio	-	3.04	-	-
PB Ratio	0.69	0.60	-	-
P/FCF Ratio	-0.91	-0.88	-	-
P/OCF Ratio	-0.91	-0.89	-	-
EV/Sales Ratio	-	-1.70	-1.05	-1.57
EV/EBITDA Ratio	0.20	0.62	2.88	-4.44
EV/EBIT Ratio	0.20	0.59	2.52	-4.71
EV/FCF Ratio	0.22	0.49	1.01	3.24
Debt / Equity Ratio	0.03	0.03	-0.05	-0.03
Debt / EBITDA Ratio	-0.04	-0.06	-0.19	0.08
Debt / FCF Ratio	-0.04	-0.05	-0.07	-0.05
Quick Ratio	6.17	7.94	2.62	3.06
Current Ratio	6.72	8.57	2.81	3.23
Asset Turnover	0	0.19	0.49	-
Return on Equity (ROE)	-174.30%	2674.40%	33.80%	-
Return on Assets (ROA)	-72.50%	-53.70%	-20.50%	-
Return on Capital (ROIC)	-95.89%	-57.94%	32.84%	-41.14%
Earnings Yield	-136.67%	-93.99%	-	-
FCF Yield	-121.56%	-113.91%	-	-
Buyback Yield / Dilution	-725.97%	-365.39%	88.48%	-
Total Shareholder Return	-725.97%	-365.39%	88.48%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).